Aarti Pharmalabs Ltd. Financials: Quarterly Results
Revenue
418.38
Cr.
PAT
28.57
Cr.
EBITDA
50
Cr.
Aarti Pharmalabs Ltd. Q4FY25 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 418.33 | 386.19 | 563.78 | 537.78 | 458.03 |
| Total Income From Operations (Cr.) | 418.33 | 386.19 | 563.78 | 537.78 | 458.03 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 50 | 74.05 | 121.20 | 110.60 | 77.27 |
| P/L Before Exceptional Items & Tax (Cr.) | 39.33 | 67.25 | 114.62 | 100.63 | 71.77 |
| P/L After Tax from Ordinary Activities (Cr.) | 28.57 | 51.30 | 88.34 | 73.99 | 54.62 |
| Net Profit/Loss For the Period (Cr.) | 28.57 | 51.30 | 88.34 | 73.99 | 54.62 |
| Basic EPS | 3.08 | 5.46 | 9.75 | 8.16 | 6.03 |
FAQs
Aarti Pharmalabs Ltd. announced its quarterly results for Q4 FY2025 on May 12, 2025.
In Q4 FY2025, Aarti Pharmalabs Ltd. are as follows:
Revenue: ₹418.38 crore
Net Profit: ₹28.57 crore.
For Q4 FY2025, Aarti Pharmalabs Ltd. posted ₹418.38 crore in revenue and ₹28.57 crore in net profit.
Past quarterly results for Aarti Pharmalabs Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.